Denemek ALTIN - Özgür
Senores Pharma eyes US injectables market
Mint New Delhi
|January 14, 2025
Newly-listed Senores Pharmaceuticals aims to set up a new facility in the US to make injectables, and eyes a larger pie of government contracts and controlled substance orders through partnerships with larger drugmakers in the country, a top company official said.
The Ahmedabad-based company, which has a presence in regulated markets like the US, the UK and Canada, as well as in emerging markets, has generics formulations as well as contract manufacturing and development businesses.
On 30 December, Senores Pharma's shares listed on the National Stock Exchange at ₹600, a premium of more than 53% over the issue price of ₹391. Its initial public offering closed on 24 December, after getting subscribed a massive 93.41 times. The IPO included a fresh issue of ₹500 crore and an offer for sale of ₹82.1 crore.
The company's stock fell nearly 13% to end at ₹439 on the NSE on Monday.
Bu hikaye Mint New Delhi dergisinin January 14, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint New Delhi'den DAHA FAZLA HİKAYE
Mint New Delhi
How CCI plans to watch AI use by companies
The Competition Commission of India (CCI) on Monday proposed a self-audit for companies to keep track of how they use artificial intelligence (AI) and the data they train AI models on. Implementing such a practice comes with multiple caveats. Mint explains.
2 mins
October 08, 2025
Mint New Delhi
NAVIGATING A JOB LOSS IS NOT AS HARD AS IT SEEMS, BUT YOU SHOULD START EARLY
The best time to mend the roof is when the sun is shining, not after the rains commence. There is so much wisdom in this one sentence that it needs careful reflection. People expect life to be a smooth, sedate, upward ride, but it is anything but that. In fact, every facet of life has its ups and downs - sometimes, they are positive and at other times, they may be challenging.
3 mins
October 08, 2025
Mint New Delhi
US TARIFF-LED RISKS PERSIST FOR INDIA
The Indian economy stumbled in August, hit by the US's additional 25% tariffs on top of the 25% reciprocal levy, as external risks weighed on domestic momentum through a weakening rupee, continued selling by foreign investors, sliding stock market and slowing exports.
3 mins
October 08, 2025
Mint New Delhi
Nykaa fashion arm sashays again—spotlight on the stride
The fashion business of FSN E-Commerce Ventures Ltd (Nykaa) is showing signs of revival after several quarters of modest performance.
1 mins
October 08, 2025
Mint New Delhi
‘RBI focusing on new use cases for e-rupee’
The Reserve Bank of India (RBI) is in no rush to open up the pilots for the central bank digital currency (CBDC) to the masses and is, instead, focusing on adding more use cases to the e-rupee with a focus on cross-border transactions, T. Rabi Sankar, deputy governor of the central bank, said on Tuesday.
1 mins
October 08, 2025
Mint New Delhi
Nobel physics prize goes to pioneers of quantum mechanics
US-based scientists John Clarke, Michel Devoret and John Martinis won the 2025 Nobel Prize in Physics for “experiments that revealed quantum physics in action”, paving the way for the development of the next generation of digital technologies.
1 min
October 08, 2025
Mint New Delhi
Nvidia to continue sponsoring H-1B visas
Chipmaker Nvidia's CEO Jensen Huang said that the company will continue to sponsor H-IB visas and cover all associated costs following U.S. President Donald Trump's executive order last month that imposed a $100,000 fee on each new application, Business Insider reported on Tuesday.
1 min
October 08, 2025
Mint New Delhi
AstraZeneca to sell cancer drug in India
AstraZeneca Pharma on Tuesday said it has received approval from the national drug regulator to market a cancer treatment drug in the country.
1 min
October 08, 2025
Mint New Delhi
Fintech lending growth slows after clampdown
But delinquency and deep-stage stress are still elevated, shows report
2 mins
October 08, 2025
Mint New Delhi
CENTRAL BANK OF INDIA RATED INDIA INVOLVED BY SKOCH FOR TRANSFORMING RECRUITMENT ONBOARDING DIGITALLY
The Central Bank of India has undertaken a landmark initiative to reimagine its recruitment and onboarding practices through a comprehensive digital solution.
1 mins
October 08, 2025
Listen
Translate
Change font size